Superworth

Cytek Biosciences market cap CTKB

Share price times shares outstanding: what the whole company sells for, since 2021.

Today, Nov 2, 2026
$750M
Highest close in our data
$3.2B
Nov 2021

Cytek Biosciences is worth $750M at the close on Nov 2, 2026, at $5.77 a share.

That is up 27% over the last year and down 35% over five years.

Its highest close in our data was $3.2B in Nov 2021.

Market cap over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHighChange
2026 so far$750M$440.4M$796.8M+15%
2025$652.1M$306.5M$879.8M−21%
2024$823.1M$616.8M$1.2B−33%
2023$1.2B$590.4M$1.8B−10%
2022$1.4B$1.2B$2.1B−37%
2021$2.2B$992.6M$3.2Bn/a

Against its peers

Companies in Medical - Diagnostics & Research nearest Cytek Biosciences' size, closest first, today.

CompanyMarket cap
CTKBCytek Biosciences$750M
NRCNRC Health$536.6M
VCYTVeracyte$3.9B
CDNACareDx$4.5B
BLLNBillionToOne$5.2B
ICCCImmucell$95.9M
LNTHLantheus$6.5B
Peer median$4.2B

What the market cap tells you

Share price times shares outstanding: what the whole company sells for today.

Size, not quality. Large caps move slower and are covered more. That is all it tells you.

More on Cytek Biosciences

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.